Palm - paralemmin Gene

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 170673

Summary

Predicted to enable D3 Dopamine Receptor binding activity. Predicted to be involved in several processes, including cellular response to electrical stimulus; negative regulation of Adenylate Cyclase activity; and positive regulation of filopodium assembly. Predicted to act upstream of or within several processes, including adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; Cytoskeleton organization; and regulation of cell shape. Located in several cellular components, including apicolateral plasma membrane; basolateral plasma membrane; and dendritic spine membrane. Orthologous to human PALM (paralemmin). [provided by Alliance of Genome Resources, Apr 2022]

Palm Products (1)

mRNA Protein Name
NM_130829.2 NP_570842.1 paralemmin-1

Gene Ontology

  • Biological Process
  • Cellular Component
Biological Process GO Annotation Evidence References Source
involved in regulation of postsynapse assembly IDA
IDA: Inferred from direct assay
18287537 RGD
involved in regulation of postsynapse assembly IMP
IMP: Inferred from mutant phenotype
18287537 RGD
Cellular Component GO Annotation Evidence References Source
located in apicolateral plasma membrane IDA
IDA: Inferred from direct assay
16847661 RGD
located in axon IDA
IDA: Inferred from direct assay
16847661 RGD
located in basolateral plasma membrane IDA
IDA: Inferred from direct assay
16847661 RGD
located in dendrite membrane IDA
IDA: Inferred from direct assay
16847661 RGD
located in dendritic spine membrane IDA
IDA: Inferred from direct assay
16847661 RGD
is active in glutamatergic synapse IDA
IDA: Inferred from direct assay
18287537 RGD
is active in glutamatergic synapse IMP
IMP: Inferred from mutant phenotype
18287537 RGD
located in plasma membrane IDA
IDA: Inferred from direct assay
16847661 RGD
is active in postsynapse IDA
IDA: Inferred from direct assay
18287537 RGD
is active in postsynapse IMP
IMP: Inferred from mutant phenotype
18287537 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

paralemmin-1

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-170223 Palm oil / Phase 4
HY-P10031 SAR441255 Agonist 99.84% Phase 1
HY-120634 BMS-929075 Inhibitor / Phase 1
HY-N2041S8 Myristic acid-13C2 / Phase 1

Pre-clinical Phase

Bioactive Molecules (55)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-N2041 Myristic acid 99.88% Unkown
HY-N0773 Isovitexin Inhibitor 99.90% Unkown
HY-N2041S Myristic acid-d27 98.83% Unkown
HY-P10932A pGk13a TFA 96.92% Unkown
HY-108693 β-Tocotrienol Inducer 99.14% Unkown
HY-145519 Mu-6S-Palm-β-Glc 99.9% Unkown
HY-P0064 Palmitoyl Tetrapeptide-3 Inhibitor 99.18% Unkown
HY-W100026 Galaxolide 76.44% Unkown
HY-N2041S3 Myristic acid-d3 98.62% Unkown
HY-148702 di-Pal-MTO 98.37% Unkown
HY-D1196 Direct Blue 71 / Unkown
HY-P10031A SAR441255 TFA Agonist 99.93% Unkown
HY-N2041S6 Myristic acid-d5 98.0% Unkown
HY-W250170 Decyl glucoside (60% in water) / Unkown
HY-W013788 2-Palmitoylglycerol Agonist 99.0% Unkown
HY-N2041S2 Myristic acid-13C 99.39% Unkown
HY-N2041S7 Myristic acid-d7 99.80% Unkown
HY-P10380A palm11-PrRP31 TFA Agonist 99.44% Unkown
HY-W038795 (S)-Ethyl lactate 99.83% Unkown
HY-N2041S1 Myristic acid-d2 98.0% Unkown
HY-N2041S4 Myristic acid-13C3 99.9% Unkown
HY-W099600 Lauric anhydride 97.0% Unkown
HY-B0828 Triazophos Inhibitor 99.25% Unkown
HY-W010667 (Z)-2-(Oleoyloxy)propane-1,3-diyl dipalmitate 98.01% Unkown
HY-W111403 Calcium oxide 99.9% Unkown
HY-W585827 2-Chloro-1,3-propanediol 99.56% Unkown
HY-128430 Farnesyl acetate Inhibitor 90% Unkown
HY-148701 mono-Pal-MTO / Unkown
HY-157172 MorHap Inhibitor / Unkown
HY-D3157 Photoactive esterase probe / Unkown
HY-N19229 Dihydrocitrinone / Unkown
HY-N2041S5 Myristic acid-d1 / Unkown
HY-N20847 Windmill palm leaves polysaccharides / Unkown
HY-P10379 palm-PrRP31 Agonist / Unkown
HY-P10380 palm11-PrRP31 Agonist / Unkown
HY-P10932 pGk13a / Unkown
HY-RS10005 PALM Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10006 PALM2AKAP2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10007 PALM3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W010736A 1,2-Dipalmitoyl-rac-glycerol / Unkown
HY-W585827S 2-Chloro-1,3-propanediol-d5 / Unkown
HY-W585827S1 2-Chloro-1,3-propanediol-d5 (major) / Unkown
HY-W750719 Neurosporene / Unkown
HY-10467 HCV-796 analog Inhibitor / Unkown
HY-179357 Hydrogenated palm oil / Unkown
HY-179358 Hydrogenated palm oil glycerides / Unkown
HY-B0828S Triazophos-d5 Inhibitor / Unkown
HY-N7813 1,2-Dipalmitoyl-3-oleoylglycerol / Unkown
HY-RS18489 Palm Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24971 Palm Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W585827R 2-Chloro-1,3-propanediol (Standard) / Unkown
HY-W710399 2-Hydroxy-3-(palmitoyloxy)propyl stearate / Unkown
HY-W710976 4-Methyl-5-nonanone 98.47% Unkown
HY-W714197 Methfuroxam Inhibitor / Unkown
HY-W719989 γ-Carotene / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Palm NCBI NCBI:5064